TIPARP and cancer: More recently, PARP7, a mono-ART also known as TCDD-inducible poly-ADP-ribose polymerase (TIPARP), has emerged as a critical regulator of tumour progression by promoting cancer cell growth and suppressing antitumor immunity [5].